TransMedics (TMDX) Capital Expenditures Growth (1y) (2019 - 2026)
Powered by 
Analysis
TransMedics (TMDX) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -1.00% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -27.50% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -0.20% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 10.38% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 24.20% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 35.70% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 5.88% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -9.99% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -6.52% |
| 10 | TransMedics | 3.12 Bn | 2.64 Bn | 113.20 Mn | -21.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.85% |
| Mar 31, 2026 | 35.58% |
| Dec 31, 2025 | 14.02% |
| Sep 30, 2025 | -84.18% |
| Jun 30, 2025 | -61.81% |
| Mar 31, 2025 | -38.79% |
| Dec 31, 2024 | -67.46% |
| Sep 30, 2024 | -55.25% |
| Jun 30, 2024 | 1,621.96% |
| Mar 31, 2024 | 4,665.05% |
| Dec 31, 2023 | 1,412.95% |
| Sep 30, 2023 | 3,576.52% |
| Jun 30, 2023 | -67.61% |
| Mar 31, 2023 | -52.53% |
| Dec 31, 2022 | -13.00% |
| Sep 30, 2022 | 4,146.38% |
| Jun 30, 2022 | 1,583.79% |
| Mar 31, 2022 | 9,665.00% |
| Dec 31, 2021 | 158,750.00% |
| Sep 30, 2021 | 23.21% |